PubHawk
MedComm (2020) December 2021 PMID 34957469

SARS-CoV-2 Omicron variant: Characteristics and prevention.

Xuemei He, Weiqi Hong, Xiangyu Pan, Guangwen Lu, Xiawei Wei

Full text PDF Download social card

Mentions

23
Peak: 12 in Dec 2021
across 3 sources since Dec 2021

Extended reach

246,114
potential audience

Total likes

21

Video views

23

Mentions per month

Dec 2021 – Aug 2023

Where it's discussed

  • X / Twitter20 posts
  • Facebook2 posts
  • YouTube1 videos

AI synopsis

What people are saying

The discussions primarily focus on promoting the publication, as seen in posts encouraging submissions and sharing links, with words like 'fast-track' and 'see the characteristics and prevention' conveying urgency and importance; this indicates a recognition of the article’s significance in shaping preventive strategies against Omicron.

AgreementModerate agreement

Most discussions acknowledge the importance of the article, with some explicitly advocating for its findings or emphasizing the need for rapid dissemination, indicating general agreement on its relevance.

InterestNeutral interest

The posts show moderate interest, mainly sharing links and promoting the publication without deep personal analysis or critique.

EngagementModerate engagement

Several discussions reference the publication's content or suggest quick responses like fast-tracking submissions, reflecting some engagement but limited detailed discussion.

ImpactModerate impact

The widespread sharing and promotion suggest that the article is considered influential, especially in terms of informing public health responses, even if individual posts are brief.

Abstract in brief

  • The Omicron variant of SARS-CoV-2 was first identified in South Africa in late 2021 and quickly gained attention due to its rapid spread and numerous mutations, especially in the spike protein's receptor-binding domain (RBD).
  • It shares some mutations with previous variants of concern like Alpha, Beta, and Gamma, which raised global concerns about increased transmissibility, potential changes in severity, and immune evasion capabilities.
  • The article discusses the discovery, mutation profile, and possible prevention strategies for Omicron, emphasizing the need for ongoing monitoring and adaptive public health measures to control its spread.]
Read the full abstract

Top posts

Most liked on X and Bluesky
Ran Israeli
@RanIsraeli · X

@Trollsdenier יש דמיון מבני בין הוריאנטים, גם בחלבון הספייק.. https://t.co/xYIIwfiWwj יש חסינות צולבת מחשיפה לנגיפים קודמים. לא מהחיסון. הוא דועך לאחר כמה חודשים ולאחר מכן המחוסנים נהיים מדבקים כמו\יותר מלא מחוסנים. ראינו בקיץ 2021 את הדעיכה, והשנה שמחוסנים נדבקים יותר. https://t.co/CuUKZSoOGD https://t.co/8rZo5hhlnT

Oct 17, 2022 · 5 likes · 2 shares · 20,884 followers View post →
MedComm
@MedComm_MC · X

The #Omicron paper published in #MedComm by FAST TRACK！Please click the link and see the characteristics and #prevention of the #Omicron variant. #OmicronVirus https://t.co/r8GIrFbA3O

Dec 20, 2021 · 5 likes · 2 shares · 249 followers View post →
MedComm
@MedComm_MC · X

The #Omicron paper published in #MedComm by FAST TRACK！Please click the link and see the characteristics and #prevention of the #Omicron variant. #OmicronVirus https://t.co/cCyazRxQDk

Dec 14, 2021 · 5 likes · 3 shares · 249 followers View post →
MedComm
@MedComm_MC · X

MedComm will now fast-track #Omicron papers and waive publication fees in 2022. If you have excellent Omicron related work, please consider MedComm, we will efficiently process the paper as soon as possible. Here is a perspective about #OmicronVarient . https://t.co/cCyazRPZRs

Feb 9, 2022 · 2 likes · 1 share · 249 followers View post →
Wiley Biomedical Science
@WileyBiomedical · X

Read this #OpenAccess Accepted Article in @MedComm_MC on characteristics and prevention of the #SARSCoV2 #Omicron variant, by Xuemei He & colleagues. https://t.co/V69GCiuzFu

Dec 17, 2021 · 1 like · 57,434 followers View post →
Wiley Clinical Health
@WileyHealth · X

Read this #OpenAccess Accepted Article in @MedComm_MC on characteristics and prevention of the #SARSCoV2 #Omicron variant, by Xuemei He & colleagues. https://t.co/P520bJt6al

Dec 19, 2021 · 1 like · 2 shares · 11,921 followers View post →

All mentions

JKelleyK
@JKelleyK · X

RT @RanIsraeli: @Trollsdenier יש דמיון מבני בין הוריאנטים, גם בחלבון הספייק.. https://t.co/xYIIwfiWwj יש חסינות צולבת מחשיפה לנגיפים קודמים…

Oct 17, 2022 · 2 shares · 949 followers View post →
Ran Israeli
@RanIsraeli · X

@Trollsdenier יש דמיון מבני בין הוריאנטים, גם בחלבון הספייק.. https://t.co/xYIIwfiWwj יש חסינות צולבת מחשיפה לנגיפים קודמים. לא מהחיסון. הוא דועך לאחר כמה חודשים ולאחר מכן המחוסנים נהיים מדבקים כמו\יותר מלא מחוסנים. ראינו בקיץ 2021 את הדעיכה, והשנה שמחוסנים נדבקים יותר. https://t.co/CuUKZSoOGD https://t.co/8rZo5hhlnT

Oct 17, 2022 · 5 likes · 2 shares · 20,884 followers View post →
Wiley Biomedical Science
@WileyBiomedical · X

RT @MedComm_MC: MedComm will now fast-track #Omicron papers and waive publication fees in 2022. If you have excellent Omicron related work…

Feb 11, 2022 · 1 share · 57,434 followers View post →
MedComm
@MedComm_MC · X

MedComm will now fast-track #Omicron papers and waive publication fees in 2022. If you have excellent Omicron related work, please consider MedComm, we will efficiently process the paper as soon as possible. Here is a perspective about #OmicronVarient . https://t.co/cCyazRPZRs

Feb 9, 2022 · 2 likes · 1 share · 249 followers View post →
Arief
@glassbread_ · X

RT @PubTrend: Trending on PubMed: SARS-CoV-2 Omicron variant: Characteristics and prevention. https://t.co/OrxN8GDeVt

Jan 12, 2022 · 2 shares · 151 followers View post →
Arli AP
@arli_ap · X

RT @PubTrend: Trending on PubMed: SARS-CoV-2 Omicron variant: Characteristics and prevention. https://t.co/OrxN8GDeVt

Jan 12, 2022 · 2 shares · 1,103 followers View post →
PubMed Trending
@PubTrend · X

Trending on PubMed: SARS-CoV-2 Omicron variant: Characteristics and prevention. https://t.co/OrxN8GDeVt

Jan 12, 2022 · 2 shares · 5,164 followers View post →
Chris Hendel
@chrishendel · X

Useful paper from a few weeks back (an eternity ago). SARS‐CoV‐2 #Omicron variant: Characteristics and prevention https://t.co/VJmjxLrysw

Jan 4, 2022 · 1 like · 4,229 followers View post →
Gollanar Idwan
@Gollanar80 · X

RT @AbuYousef_T: https://t.co/Od0QXUCixS

Dec 23, 2021 · 1 share · 25,315 followers View post →
Abdelelah Alnaimat
@AAlnaimatt · X

https://t.co/Od0QXUCixS

Dec 23, 2021 · 1 like · 1 share · 1,189 followers View post →
Signal Transduction and Targeted Therapy (STTT)
@sigtrans_sttt · X

RT @MedComm_MC: The #Omicron paper published in #MedComm by FAST TRACK！Please click the link and see the characteristics and #prevention…

Dec 20, 2021 · 2 shares · 520 followers View post →
Molecular Biomedicine
@Mol_Biomed · X

RT @MedComm_MC: The #Omicron paper published in #MedComm by FAST TRACK！Please click the link and see the characteristics and #prevention…

Dec 20, 2021 · 2 shares · 241 followers View post →
MedComm
@MedComm_MC · X

The #Omicron paper published in #MedComm by FAST TRACK！Please click the link and see the characteristics and #prevention of the #Omicron variant. #OmicronVirus https://t.co/r8GIrFbA3O

Dec 20, 2021 · 5 likes · 2 shares · 249 followers View post →
Dark Brandon Rises
@iamgabbarson · X

RT @WileyHealth: Read this #OpenAccess Accepted Article in @MedComm_MC on characteristics and prevention of the #SARSCoV2 #Omicron variant,…

Dec 19, 2021 · 2 shares · 544 followers View post →
Wiley Clinical Health
@WileyHealth · X

Read this #OpenAccess Accepted Article in @MedComm_MC on characteristics and prevention of the #SARSCoV2 #Omicron variant, by Xuemei He & colleagues. https://t.co/P520bJt6al

Dec 19, 2021 · 1 like · 2 shares · 11,921 followers View post →
Wiley Biomedical Science
@WileyBiomedical · X

Read this #OpenAccess Accepted Article in @MedComm_MC on characteristics and prevention of the #SARSCoV2 #Omicron variant, by Xuemei He & colleagues. https://t.co/V69GCiuzFu

Dec 17, 2021 · 1 like · 57,434 followers View post →
Wiley Biomedical Science
@WileyBiomedical · X

RT @MedComm_MC: The #Omicron paper published in #MedComm by FAST TRACK！Please click the link and see the characteristics and #prevention…

Dec 15, 2021 · 3 shares · 57,434 followers View post →
Signal Transduction and Targeted Therapy (STTT)
@sigtrans_sttt · X

RT @MedComm_MC: The #Omicron paper published in #MedComm by FAST TRACK！Please click the link and see the characteristics and #prevention…

Dec 14, 2021 · 3 shares · 520 followers View post →
Molecular Biomedicine
@Mol_Biomed · X

RT @MedComm_MC: The #Omicron paper published in #MedComm by FAST TRACK！Please click the link and see the characteristics and #prevention…

Dec 14, 2021 · 3 shares · 241 followers View post →
MedComm
@MedComm_MC · X

The #Omicron paper published in #MedComm by FAST TRACK！Please click the link and see the characteristics and #prevention of the #Omicron variant. #OmicronVirus https://t.co/cCyazRxQDk

Dec 14, 2021 · 5 likes · 3 shares · 249 followers View post →